跳至主要内容
临床试验/JPRN-UMIN000024890
JPRN-UMIN000024890招募中未知

Diffusion-Weighted Magnetic REsonance Imaging Assessment of Liver Metastasis to Improve Surgical Planning (EORTC-1527-GITCG-IG/ JCOG1609INT, DREAM)

European Organisation for Research and Treatment of Cancer (EORTC)0 个研究点目标入组 400 人开始时间: 2016年11月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • Criteria for registration
  • ? Age >=18 years old
  • ? Before patient registration, written informed consent must be given according to ICH/GCP, and national/local regulations
  • Criteria for Eligibility
  • ? Primary tumor histologically proven as colorectal adenocarcinoma
  • ? Unresectable or borderline resectable liver metastases at the time of diagnosis for liver metastases.
  • ? Presence of extrahepatic distant metastases is allowed as long as these lesions are considered as resectable
  • ? Contrast-enhanced thorax, abdomen and pelvic CT scanat diagnosis is available
  • ? Multiparametric MRI is available.
  • ? No contraindications to any contrast agents for CT and MRI or MRI procedure
  • ? WHO performance status of 0 or 1
  • ? Previous treatments for primary, liver and extra-hepatic metastases are allowed.
  • ? No significant comorbidity that will preclude either conversion therapy or surgery
  • ? No other malignancies in the 3 years prior to study entry
  • ? Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
  • ? Pregnancy is a contraindication in this study.
  • Criteria for Enrollment
  • ? At least 2 cycles of chemotherapy have been given as a part of conversion therapy. Any regimen and schedule of chemotherapy are allowed.
  • ? At least 2 sets (at liver metastasis diagnosis and preoperative) of contrast-enhanced CT scan are available
  • ? At least 2 sets of multiparametric MRI (baseline and preoperative) are available
  • ? Interval between the two MRIs should be at least 4 weeks.
  • ? Patient is suitable for hepatic resection based on the assessment of MDT prior to any liver surgery. MDT is composed of at least an expert liver/colorectal surgeon, Gastrointestinal (GI) radiologist and oncologist prior to any liver surgery. Attendance of pathologist is recommended
  • ? Hepatic resection is scheduled within 8 weeks of latest imaging.

排除标准

  • 未提供

研究者

发起方
European Organisation for Research and Treatment of Cancer (EORTC)

相似试验